The Toll-like receptor 2 R753Q polymorphism defines a subgroup of patients with atopic dermatitis having severe phenotype
- 1 March 2004
- journal article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 113 (3) , 565-567
- https://doi.org/10.1016/j.jaci.2003.12.583
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- TLR4 gene variants modify endotoxin effects on asthmaJournal of Allergy and Clinical Immunology, 2003
- Polymorphisms in Toll-Like Receptor 4 Are Not Associated with Asthma or Atopy-related PhenotypesAmerican Journal of Respiratory and Critical Care Medicine, 2002
- Endogenous Antimicrobial Peptides and Skin Infections in Atopic DermatitisNew England Journal of Medicine, 2002
- Staphylococcus aureus: colonizing features and influence of an antibacterial treatment in adults with atopic dermatitisBritish Journal of Dermatology, 2002
- Relevance of Mutations in the TLR4 Receptor in Patients With Gram-Negative Septic ShockArchives of internal medicine (1960), 2002
- Determination of the TLR4 Genotype Using Allele-Specific PCRBioTechniques, 2001
- Detection of Toll-like receptor 2 (TLR2) mutation in the lepromatous leprosy patientsFEMS Immunology & Medical Microbiology, 2001
- A Novel Polymorphism in the Toll-Like Receptor 2 Gene and Its Potential Association with Staphylococcal InfectionInfection and Immunity, 2000
- TLR4 mutations are associated with endotoxin hyporesponsiveness in humansNature Genetics, 2000
- Prevalence and role of serum IgE antibodies to the StaphylococcuS aureus–derived superantigens SEA and SEB in children with atopic dermatitisJournal of Allergy and Clinical Immunology, 1999